Associated Banc-Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
SGH
Associated Banc-Corp's XBI Position: Q3 2026 in Review
Associated Banc-Corp reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.02% in Q3 2026, selling an estimated $158 and leaving 6,638 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #214.
Associated Banc-Corp first reported a position in XBI in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.2M in Q3 2024. 375 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Associated Banc-Corp held 6,638 shares of State Street SPDR S&P Biotech ETF worth $1.05M as of Q3 2026.
- Associated Banc-Corp sold 1 State Street SPDR S&P Biotech ETF share in Q3 2026, an estimated $158.
- State Street SPDR S&P Biotech ETF made up 0.02% of Associated Banc-Corp's portfolio in Q3 2026, its #214 holding.
- Associated Banc-Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 18 quarters since.
- Associated Banc-Corp's State Street SPDR S&P Biotech ETF position peaked at $1.2M in Q3 2024.
- 375 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Associated Banc-Corp's 13F filing for Q3 2026, filed 30 Oct 2026.